We conclude that AEAC alone does not affect cell viability and growth as strongly as other Hsp70 inhibitors do, and tested it in combination with doxorubicin for anti-tumor activity in rat glioblastoma C6 and mouse melanoma B16 cells. This evidence concerns the gene HSPA1A and glioblastoma.